PERIPHERAL NEUROPATHY: ASSOCIATION WITH AGE AND SURVIVAL IN MULTIPLE MYELOMA PATIENTS


Silay K., Akinci S., Ulas A., Guney T., Yalcin A., Dilek I.

ACTA MEDICA MEDITERRANEA, vol.32, no.1, pp.123-126, 2016 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.19193/0393-6384_2016_1_19
  • Title of Journal : ACTA MEDICA MEDITERRANEA
  • Page Numbers: pp.123-126

Abstract

Objective: Multiple myeloma (MM) accounts for approximately 1% of all cancers and 10% of hematologic malignancies. Peripheral neuropathy (PN) is a common side effect of cancer therapy that can have an impact on quality of life and survivorship. PN may happen in MM due to adverse effect of chemotherapeutics, amyloidosis or as a part of paraneoplastic syndrome. The aim of this study is to evaluate the prevalence of peripheral neuropathy in multiple myeloma patients and its association with age and disease outcome.